Ulrike Falks is Quality Head for all BioPharma Sites of Boehringer-Ingelheim in Europe, USA and China; Drug Substance and Drug Product; CMB and internal products as well as Combination Products; Launch and Innovation Quality, 3Party Quality Management and Quality Systems are also part of the network, embracing around 2000 colleagues worldwide

Boehringer Ingelheim develops breakthrough therapies that change lives - today and for generations to come. Family-owned since its foundation in 1885, Boehringer Ingelheim is now one of the world's leading research-based pharmaceutical companies, serving over 130 markets. The company has set itself the goal of creating new value through innovation, particularly in areas of high unmet medical need. There are around 53,000 employees in the three divisions Human Pharmaceuticals, Animal Health and Biopharmaceuticals.